UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients

Journal of neuroinflammation, 2018-07, Vol.15 (1), p.205-205, Article 205

2018

Volltextzugriff (PDF)

Proteins Do Not Replicate, They Precipitate: Phase Transition and Loss of Function Toxicity in Amyloid Pathologies

Biology (Basel, Switzerland), 2022-03, Vol.11 (4), p.535

2022

Volltextzugriff (PDF)

Are smartphones and machine learning enough to diagnose tremor?

Journal of neurology, 2022-11, Vol.269 (11), p.6104-6115

2022

Volltextzugriff (PDF)

High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis

EClinicalMedicine, 2021-08, Vol.38, p.100988-100988, Article 100988

2021

Volltextzugriff (PDF)

When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis

Journal of neurology, 2021-09, Vol.268 (9), p.3203-3211

2021

Volltextzugriff (PDF)

Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology

Frontiers in neuroscience, 2020-04, Vol.14, p.256

2020

Volltextzugriff (PDF)

DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease

Translational neurodegeneration, 2024-06, Vol.13 (1), p.31-4

2024

Volltextzugriff (PDF)

Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology

International journal of molecular sciences, 2021-07, Vol.22 (14), p.7292

2021

Volltextzugriff (PDF)

Skin Cancer May Delay Onset but Not Progression of Parkinson's Disease: A Nested Case-Control Study

Frontiers in neurology, 2020-05, Vol.11, p.406-406

2020

Volltextzugriff (PDF)

Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician's Perspective

Brain sciences, 2024, Vol.14 (2), p.151

2024

Volltextzugriff (PDF)

Soluble Amyloid-β Consumption in Alzheimer’s Disease

Journal of Alzheimer's disease, 2021-01, Vol.82 (4), p.1403-1415

2021

Volltextzugriff (PDF)

Plasma NfL, clinical subtypes and motor progression in Parkinson's disease

Parkinsonism & related disorders, 2021-06, Vol.87, p.41-47

2021

Volltextzugriff (PDF)

The theoretical problems of “prodrome” and “phenoconversion” in neurodegeneration

Handbook of Clinical Neurology, 2023, Vol.192, p.155-167

2023

Volltextzugriff (PDF)

Increased CSF DOPA Decarboxylase Correlates with Lower DaT-SPECT Binding: Analyses in Biopark and PPMI Cohorts

Movement disorders, 2024-05

2024

Volltextzugriff (PDF)

The shift to a proteinopenia paradigm in neurodegeneration

Handbook of Clinical Neurology, 2023, Vol.193, p.23-32

2023

Volltextzugriff (PDF)

Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis

Journal of neurology, neurosurgery and psychiatry, 2020-04, Vol.91 (4), p.426-433

2020

Volltextzugriff (PDF)

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels

Movement disorders, 2022-10, Vol.37 (10), p.2129-2134

2022

Volltextzugriff (PDF)

Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension

Annals of neurology, 2021-01, Vol.89 (1), p.91-98

2021

Volltextzugriff (PDF)

Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential

Neurotherapeutics, 2020-10, Vol.17 (4), p.1736-1746

2020

Volltextzugriff (PDF)

High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations

Journal of Alzheimer's disease, 2022, Vol.90 (1), p.333-348

2022

Volltextzugriff (PDF)

Continuous Monitoring of Orthostatic Hypotension and Instability Events in Parkinson Disease (P2.8-002)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Movement disorders associated with neuronal antibodies: a data-driven approach

Journal of neurology, 2022-07, Vol.269 (7), p.3511-3521

2022

Volltextzugriff (PDF)

The VDR FokI (rs2228570) polymorphism is involved in Parkinson's disease

Journal of the neurological sciences, 2021-09, Vol.428, p.117606-117606, Article 117606

2021

Volltextzugriff (PDF)

Technology-based assessment of motor and nonmotor phenomena in Parkinson disease

Expert review of neurotherapeutics, 2018-11, Vol.18 (11), p.825-845

2018

Volltextzugriff (PDF)

Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension

Parkinsonism & related disorders, 2022-06, Vol.99, p.62-64

2022

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(48)
Berichte
(2)

Sprache

Englisch
(50)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients

Proteins Do Not Replicate, They Precipitate: Phase Transition and Loss of Function Toxicity in Amyloid Pathologies

Are smartphones and machine learning enough to diagnose tremor?

High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis

When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis

Disentangling the Amyloid Pathways: A Mechanistic Approach to Etiology

DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease

Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology

Skin Cancer May Delay Onset but Not Progression of Parkinson's Disease: A Nested Case-Control Study

Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician's Perspective

Soluble Amyloid-β Consumption in Alzheimer’s Disease

Plasma NfL, clinical subtypes and motor progression in Parkinson's disease

The theoretical problems of “prodrome” and “phenoconversion” in neurodegeneration

Increased CSF DOPA Decarboxylase Correlates with Lower DaT-SPECT Binding: Analyses in Biopark and PPMI Cohorts

The shift to a proteinopenia paradigm in neurodegeneration

Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels

Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension

Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential

High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations

Continuous Monitoring of Orthostatic Hypotension and Instability Events in Parkinson Disease (P2.8-002)

Movement disorders associated with neuronal antibodies: a data-driven approach

The VDR FokI (rs2228570) polymorphism is involved in Parkinson's disease

Technology-based assessment of motor and nonmotor phenomena in Parkinson disease

Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension

Suchergebnisse filtern